Used in pharmaceutical research as a boron-containing compound with potential anti-inflammatory and anticancer properties. The presence of the benzoxaborole moiety enhances its ability to interact with biological targets, particularly enzymes involved in cellular signaling pathways. It has shown promise as a scaffold for developing proteasome inhibitors and anti-infective agents due to the unique reactivity of the boron atom. Its α,β-unsaturated ketone structure allows for Michael addition reactions, making it valuable in designing covalent inhibitors. Also investigated for use in targeted therapies where selective binding and sustained activity are required.